Amber Therapeutics announces successful first-in-human impla

Amber-UI presents a unique and significant opportunity to treat urge and mixed urinary incontinence by targeting the pudendal nerveAmber-UI can sense, interpret, adapt and respond to individual

Related Keywords

United Kingdom , London , City Of , Belgium , Charles Knowles , Kostenloser Wertpapierhandel , Tim Denison , Frazer Hall Mark , Aidan Crawley , Professor Of Urology At Antwerp University , Bioinduction Limited Bristol , University Of Oxford , Oxford Science Enterprises , Picostim Dyneumo Research Platform , University Hospital Antwerp Belgium , Augmenting Urinary Reflex Activity , University Hospital Antwerp , Stefan De Wachter , Bioinduction Limited , Picostim Deep Brain Stimulation , Antwerp University , Chief Scientific Officer , Emerging Technology , Chief Medical Officer , Queen Mary University , Urinary Incontinence , Current Neuromodulation , Mark Swallow , Sandi Greenwood , Amber , Herapeutics , Nnounces , Uccessful , First , Human , Implants , Intelligent , Closed , Loop , Ioelectrical , Therapy , Surge , Ixed , Urinary , Incontinence ,